Jagsonpal Pharmaceuticals Ltd.
BSE: 507789 | Sector: Health care |
NSE: JAGSNPHARM | ISIN Code: INE048B01027 |
BSE 12:56 | 07 Feb | 328.25 |
-0.05 (-0.02%) |
OPEN
330.95 |
HIGH
331.95 |
LOW
325.00 |
NSE 12:49 | 07 Feb | 328.00 |
0.45 (0.14%) |
OPEN
327.05 |
HIGH
331.85 |
LOW
324.05 |
OPEN | 330.95 |
PREVIOUS CLOSE | 328.30 |
VOLUME | 683 |
52-Week high | 420.20 |
52-Week low | 156.75 |
P/E | 41.71 |
Mkt Cap.(Rs cr) | 860 |
Buy Price | 327.00 |
Buy Qty | 101.00 |
Sell Price | 328.45 |
Sell Qty | 2.00 |
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) - Market Capital
Market Cap
COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
Sun Pharma.Inds. | 1005.40 | -1.77 | 1071.90 | 789.75 | 241225.61 |
Cipla | 1024.35 | -0.52 | 1185.20 | 880.00 | 82680.41 |
Dr Reddy's Labs | 4431.80 | 1.88 | 4645.55 | 3655.00 | 73798.34 |
Divi's Lab. | 2753.25 | -0.90 | 4640.95 | 2740.10 | 73085.02 |
Apollo Hospitals | 4338.85 | 0.50 | 5015.45 | 3365.90 | 62383.98 |
Torrent Pharma. | 1530.70 | -0.59 | 1722.70 | 1242.50 | 51805.01 |
Zydus Lifesci. | 476.50 | 1.35 | 478.95 | 319.40 | 48231.33 |
Abbott India | 20847.55 | -0.16 | 22481.80 | 15525.00 | 44301.04 |
Max Healthcare | 439.95 | -0.10 | 482.50 | 306.00 | 42712.99 |
Alkem Lab | 3050.05 | -0.63 | 3720.00 | 2835.00 | 36463.35 |
Lupin | 745.15 | 0.01 | 916.00 | 583.05 | 33896.87 |
Biocon | 237.95 | -1.33 | 410.50 | 229.70 | 28568.28 |
Aurobindo Pharma | 416.40 | 0.23 | 730.00 | 397.30 | 24396.88 |
Syngene Intl. | 559.30 | -0.13 | 682.25 | 508.10 | 22451.98 |
Ipca Labs. | 861.55 | 0.33 | 1089.00 | 830.00 | 21857.52 |
Glaxosmi. Pharma | 1234.55 | -0.32 | 1734.90 | 1230.70 | 20914.51 |
Fortis Health. | 277.00 | 0.07 | 324.80 | 219.80 | 20912.39 |
Gland Pharma | 1221.25 | 4.02 | 3599.00 | 1170.10 | 20113.99 |
Laurus Labs | 330.55 | -1.06 | 626.00 | 324.25 | 17805.08 |
Pfizer | 3874.45 | 0.23 | 4700.00 | 3768.00 | 17725.61 |
Quick Links for Jagsonpal Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices